Image For Activity Cover
An Overview of Reimbursement for MAT: Utilizing the Toolkit and Telehealth Updates (On-Demand)
Overview




Presenter(s):
Joel V. Brill, MD

 

Target Audience: This activity is designed for physicians, nurse practitioners, physician assistants, and other practitioners who treat and bill for insurance for patients with a substance use disorder either in-person or through telehealth.  

Webinar Description: This 1-hour webinar covers professional practice gaps of addiction specialist physicians and other practitioners seeking guidance about existing billing codes that may be used to bill for services provided to patients with substance use disorder (SUD). This webinar will cover information contained in the Reimbursement for Medications for Addiction Treatment Toolkit, information on final changes to opioid treatment programs (OTP) and relevant telehealth offerings in the Medicare program for calendar year (CY) 2022, case studies, billing guidance, as well as best practices. 


Educational Objectives:

  • Demonstrate an understanding of codes available to bill for treatment of a SUD;
  • Describe the federal changes to telehealth policies in outpatient and OTP treatment programs;
  • Explain federal Medicaid policies around the treatment of SUD using telehealth;
  • Describe alternative payment model arrangements indicated for treating SUD; and
  • Identify strategies for addressing issues related to the payment of claims for the treatment of SUD.

Support for the Program:
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By